Mundipharma A/S: Financial statements 2023
CVR: 17981994
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Mundipharma A/S (CVR 17981994) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 35,938,000 and a net result of DKK 897,000 compared with DKK 709,000 the year before. That is a decrease of 10.4% compared with the year before. The profit margin was 2.5%. Equity in the 2023 report amounted to DKK 36,979,000. The solvency ratio was 75.9%. The company had 2 employees in the financial year.
- Revenue
- DKK 35,938,000
- Gross Profit
- DKK 3,082,000
- Profit/Loss
- DKK 897,000
- Equity
- DKK 36,979,000
- Total Assets
- DKK 48,751,000
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 35.9M | 3.1M | 897K | 37M | 2 |
| 2022 | 40.1M | 6.8M | 709K | 49.8M | 4 |
| 2021 | 48.5M | 10.5M | 910K | 49.1M | 9 |
| 2020 | 51.6M | 30.8M | 908K | 48.2M | 21 |
| 2019 | 53.5M | 27M | 23K | 47.3M | 25 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Mundipharma A/S has published its annual report for 2022. Revenue came to DKK 40,102,000, and the net result was DKK 709,000.
As of June 30, 2023, Hywel Rhys Day has joined the board of directors of Mundipharma A/S.
As of June 30, 2023, Floris Anne Everard Bongenaar has joined the board of directors of Mundipharma A/S.
As of June 30, 2023, Jennie Maria Synnöve Tjernström has left the board of directors of Mundipharma A/S.
As of June 30, 2023, Hywel Rhys Day is registered as adm. dir. of Mundipharma A/S.
As of June 30, 2023, Jennie Maria Synnöve Tjernström has stepped down as adm. dir. of Mundipharma A/S.
About Mundipharma A/S
Mundipharma A/S is a Danish company of the type Aktieselskab based in Vedbæk, founded in 1994. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Norpharma A/S and NORPHARMA A/S. The management consists of Lisbeth Kattenhøj. The board consists of Stephen Johan Jamieson (chair), Bryan George Lea and Lisbeth Kattenhøj. The company is owned by Halm S.à.r.l., RSS Captain Trust Holdings LLC and JDS Captain Trust Holdings LLC. The company has 3 employees (2026). In 2025, the company reported revenue of DKK 25,912,000 and a net result of DKK 672,000 compared with DKK 514,000 the year before. Equity in the 2025 report amounted to DKK 38,165,000.
